Novel radiation and targeted therapy combinations for improving rectal cancer outcomes
Neoadjuvant radiotherapy (RT) is commonly used as standard treatment for rectal cancer. However, response rates are variable and survival outcomes remain poor, highlighting the need to develop new therapeutic strategies. Research is focused on identifying novel methods for sensitising rectal tumours...
Saved in:
| Main Authors: | Kathryn Pennel, Louise Dutton, Lydia Melissourgou-Syka, Campbell Roxburgh, Joanna Birch, Joanne Edwards |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Cambridge University Press
2024-01-01
|
| Series: | Expert Reviews in Molecular Medicine |
| Subjects: | |
| Online Access: | https://www.cambridge.org/core/product/identifier/S1462399424000152/type/journal_article |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The role of chemoradiotherapy in the treatment of neuroendocrine rectal cancer: case reports
by: S. S. Gordeev, et al.
Published: (2022-09-01) -
Research progress on immunotherapy combined with neoadjuvant concurrent chemoradiotherapy in pMMR/MSS locally advanced rectal cancer
by: Yang He, et al.
Published: (2025-08-01) -
Dependence receptors: new targets for cancer therapy
by: Morgan Brisset, et al.
Published: (2021-09-01) -
Understanding and considerations of radiation-induced rectal and anal injury after neoadjuvant chemoradiotherapy for rectal cancer
by: Zhu Xiaoming, et al.
Published: (2023-10-01) -
Intra-arterial chemoembolization as a component of neoadjuvant treatment of rectal cancer. Literature review
by: R. E. Kalinin, et al.
Published: (2024-11-01)